Exchange: NASDAQ·Updated 03:58 PM EDT

KLRAKailera Therapeutics Inc.

$19.91
$0.78
(4.08%)
Today
Reported EarningsMay 26
Mkt Cap$2.48B
Vol634,626.00
67

Bullish Sentiment

How do you feel about KLRA?

About

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
145

Frequently Asked Questions

What is Market Cap of Kailera Therapeutics Inc.?
What is the 52-week high for Kailera Therapeutics Inc.?
What is the 52-week low for Kailera Therapeutics Inc.?
What is Kailera Therapeutics Inc. stock price today?
What was Kailera Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Kailera Therapeutics Inc.?
What is the 50-day moving average of Kailera Therapeutics Inc.?
How many employees does Kailera Therapeutics Inc. have?

Advertisement|Remove ads.